Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00204)
| DIG Name |
Myristic acid
|
||||
|---|---|---|---|---|---|
| Synonyms |
Tetradecanoic acid; MYRISTIC ACID; 544-63-8; n-Tetradecanoic acid; Crodacid; n-Tetradecoic acid; 1-Tridecanecarboxylic acid; n-Tetradecan-1-oic acid; Hydrofol acid 1495; Univol U 316S; Emery 655; Myristinsaeure; Myristate; tetradecoic acid; Hystrene 9014; Neo-fat 14; C14 fatty acid; Myristic acid, pure; n-Myristic acid; Myristic acid (natural); Tetradecanoate; acide tetradecanoique; NSC 5028; FEMA No. 2764; CCRIS 4724; CH3-[CH2]12-COOH; HSDB 5686; C14:0; UNII-0I3V7S25AW; Philacid 1400; CHEBI:28875; AI3-15381; Prifac 2942; MFCD00002744; 1-tetradecanecarboxylic acid; 0I3V7S25AW; CHEMBL111077; NSC5028; Myristic acid, 99%; DSSTox_CID_1666; n-tetradecan-1-oate; DSSTox_RID_76274; DSSTox_GSID_21666; CAS-544-63-8; Myristic acid [NF]; EINECS 208-875-2; BRN 0508624; myristoate; myristoic acid; Lead dimyristate; n-Tetradecanoate; 3usx; Myristic acid pure; Myristic Acid Flake; Hystrene 9514; Kortacid 1499; Edenor C 14; Myristic Acid 655; 1-Tridecanecarboxylate; Prifrac 2942; MAGNESIUMARSENATE; Myristic acid, 95%; Myristic acid, natural; tridecanecarboxylic acid; Myristic acid (8CI); Myristic Acid, Reagent; 3v2n; 3w9k; Myristic acid, puriss.; ACMC-1AKMJ; 32112-52-0; Tetradecanoic acid (9CI); bmse000737; Epitope ID:176772; SCHEMBL6374; 4-02-00-01126 (Beilstein Handbook Reference); MLS002152942; WLN: QV13; Tetradecanoic (Myristic) acid; Myristic acid-[9,10-3H]; CCCCCCCCCCCCCC([O])=O; GTPL2806; DTXSID6021666; s161; HMS3039E15; HMS3648O20; Myristic acid, analytical standard; HY-N2041; MYRISTIC-1,2-13C2 ACID; NSC-5028; TETRADECANOIC-6,6-D2 ACID; ZINC1530417; EINECS 250-924-5; Myristic acid, >=98.0% (GC); Tox21_201852; Tox21_302781; ANW-32091; BDBM50147581; LMFA01010014; s5617; SBB060024; STL185697; Myristic acid, >=95%, FCC, FG; Myristic acid, Sigma Grade, >=99%; AKOS009156714; CCG-266785; DB08231; DS-3833; MCULE-9671122893; NE10225; NCGC00091068-01; NCGC00091068-02; NCGC00091068-03; NCGC00256547-01; NCGC00259401-01; AK114664; SMR001224536; ST023797; CS-0018531; FT-0602832; FT-0770860; M0476; EN300-78099; Myristic acid-13,13,14,14,14-[d5]; C06424; Myristic acid, Vetec(TM) reagent grade, 98%; Q422658; SR-01000854525; SR-01000854525-3; W-109088; F8889-5016; EDAE4876-C383-4AD4-A419-10C0550931DB; UNII-13FB83DEYU component TUNFSRHWOTWDNC-UHFFFAOYSA-N; UNII-5U9XZ261ER component TUNFSRHWOTWDNC-UHFFFAOYSA-N; UNII-96GS7P39SN component TUNFSRHWOTWDNC-UHFFFAOYSA-N; UNII-Q8Y7S3B85M component TUNFSRHWOTWDNC-UHFFFAOYSA-N; UNII-79P21R4317 component TUNFSRHWOTWDNC-UHFFFAOYSA-N; Myristic acid, United States Pharmacopeia (USP) Reference Standard; Tetradecanoic acid; 1-Tridecanecarboxylic acid; n-Tetradecanoic acid; Myristic acid, Pharmaceutical Secondary Standard; Certified Reference Material; 124511-74-6; 30719-21-2; 327077-03-2; 72878-02-5
|
||||
| DIG Function |
Emulsifying agent; Penetration agent; lubricant
|
||||
| Formula |
C14H28O2
|
||||
| Canonical SMILES |
CCCCCCCCCCCCCC(=O)O
|
||||
| InChI |
1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)
|
||||
| InChIKey |
TUNFSRHWOTWDNC-UHFFFAOYSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 228.37 | Topological Polar Surface Area | 37.3 | |
| XlogP | 5.3 | Complexity | 155 | ||
| Heavy Atom Count | 16 | Rotatable Bond Count | 12 | ||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||